Net Income (Loss) Attributable to Parent in USD of ASENSUS SURGICAL, INC. from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ASENSUS SURGICAL, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q2 2024.
  • ASENSUS SURGICAL, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2024 was -$25,749,000.000, a 24.6% decline year-over-year.
  • ASENSUS SURGICAL, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2024 was -$83,799,000.000, a 5.15% decline year-over-year.
  • ASENSUS SURGICAL, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$78,433,000.000, a 3.8% decline from 2022.
  • ASENSUS SURGICAL, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$75,561,000.000, a 21% decline from 2021.
  • ASENSUS SURGICAL, INC. annual Net Income (Loss) Attributable to Parent for 2021 was -$62,462,000.000, a 5.31% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

ASENSUS SURGICAL, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$83,799,000 -$25,749,000 -$5,087,000 -24.6% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 -$78,712,000 -$22,497,000 -$279,000 -1.3% 01 Jan 2024 31 Mar 2024 10-Q 13 Aug 2024
Q4 2023 -$78,433,000 -$17,235,000 +$655,000 +3.7% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2024
Q3 2023 -$79,088,000 -$18,318,000 +$606,000 +3.2% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 -$79,694,000 -$20,662,000 -$1,043,000 -5.3% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$78,651,000 -$22,218,000 -$3,090,000 -16.2% 01 Jan 2023 31 Mar 2023 10-Q 13 Aug 2024
Q4 2022 -$75,561,000 -$17,890,000 -$2,009,000 -12.6% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$73,552,000 -$18,924,000 -$2,855,000 -17.8% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$70,697,000 -$19,619,000 -$6,447,000 -48.9% 01 Apr 2022 30 Jun 2022 10-Q 14 Nov 2023
Q1 2022 -$64,250,000 -$19,128,000 -$1,788,000 -10.3% 01 Jan 2022 31 Mar 2022 10-Q 14 Nov 2023
Q4 2021 -$62,462,000 -$15,881,000 -$2,089,000 -15.1% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 -$60,373,000 -$16,069,000 -$987,000 -6.5% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$59,386,000 -$13,172,000 +$668,000 +4.8% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$60,054,000 -$17,340,000 -$742,000 -4.5% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$59,312,000 -$13,792,000 -$58,000 -0.42% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 -$59,254,000 -$15,082,000 +$82,689,000 +84.6% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 -$141,943,000 -$13,840,000 +$6,331,000 +31.4% 01 Apr 2020 30 Jun 2020 10-Q 03 Nov 2021
Q1 2020 -$148,274,000 -$16,598,000 +$5,927,000 +26.3% 01 Jan 2020 31 Mar 2020 10-Q 03 Nov 2021
Q4 2019 -$154,201,000 -$13,734,000 -$7,293,000 -1.1% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022
Q3 2019 -$146,908,000 -$97,771,000 -$77,565,000 -3.8% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$69,343,000 -$20,171,000 +$14,077,000 +41.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Nov 2020
Q1 2019 -$83,420,000 -$22,525,000 -$21,643,000 -24.5% 01 Jan 2019 31 Mar 2019 10-Q 05 Nov 2020
Q4 2018 -$61,777,000 -$6,441,000 +$69,715,000 +91.5% 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2019
Q3 2018 -$131,492,000 -$20,206,000 +$18,307,000 +47.5% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$149,799,000 -$34,248,000 -$19,535,000 -1.3% 01 Apr 2018 30 Jun 2018 10-Q 12 Nov 2019
Q1 2018 -$130,264,000 -$882,000 +$14,532,000 +94.3% 01 Jan 2018 31 Mar 2018 10-Q 12 Nov 2019
Q4 2017 -$144,796,000 -$76,156,000 -$62,164,000 -4.4% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 -$82,632,000 -$38,513,000 -$25,569,000 -2% 01 Jul 2017 30 Sep 2017 10-K 27 Feb 2019
Q2 2017 -$57,063,000 -$14,713,000 +$65,418,000 +81.6% 01 Apr 2017 30 Jun 2017 10-K 27 Feb 2019
Q1 2017 -$122,481,000 -$15,414,000 -$2,501,000 -19.4% 01 Jan 2017 31 Mar 2017 10-K 27 Feb 2019
Q4 2016 -$119,980,000 -$13,992,000 -$413,000 -3% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 -$119,567,000 -$12,944,000 +$957,000 +6.9% 01 Jul 2016 30 Sep 2016 10-K 08 Mar 2018
Q2 2016 -$120,524,000 -$80,131,000 -$70,783,000 -7.6% 01 Apr 2016 30 Jun 2016 10-K 08 Mar 2018
Q1 2016 -$49,741,000 -$12,913,000 -$2,793,000 -27.6% 01 Jan 2016 31 Mar 2016 10-K 08 Mar 2018
Q4 2015 -$46,948,000 -$13,579,000 -$5,500,000 -68.1% 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2017
Q3 2015 -$41,448,000 -$13,901,000 -$2,394,000 -20.8% 01 Jul 2015 30 Sep 2015 10-K 06 Mar 2017
Q2 2015 -$39,054,000 -$9,348,000 +$1,239,000 +11.7% 01 Apr 2015 30 Jun 2015 10-K 06 Mar 2017
Q1 2015 -$40,293,000 -$10,120,000 -$2,641,000 -35.3% 01 Jan 2015 31 Mar 2015 10-K 06 Mar 2017
Q4 2014 -$37,652,000 -$8,079,000 +$3,277,000 +28.9% 01 Oct 2014 31 Dec 2014 10-K 03 Mar 2016
Q3 2014 -$40,929,000 -$11,507,000 -$242,000 -2.1% 01 Jul 2014 30 Sep 2014 10-K 03 Mar 2016
Q2 2014 -$40,687,000 -$10,587,000 -$9,627,000 -10% 01 Apr 2014 30 Jun 2014 10-K 03 Mar 2016
Q1 2014 -$31,060,000 -$7,479,000 -$2,702,000 -56.6% 01 Jan 2014 31 Mar 2014 10-K 03 Mar 2016
Q4 2013 -$28,358,000 -$11,356,000 -$3,740,000 -49.1% 01 Oct 2013 31 Dec 2013 10-K 03 Mar 2016
Q3 2013 -$24,618,000 -$11,265,000 -$7,595,000 -2.1% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 -$17,023,000 -$960,000 +$1,042,000 +52% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2013
Q1 2013 -$18,065,000 -$4,777,000 -$2,640,000 -1.2% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q4 2012 -$15,425,000 -$7,616,000 -$6,007,000 -3.7% 01 Oct 2012 31 Dec 2012 10-K 05 Mar 2014
Q3 2012 -$9,418,000 -$3,670,000 -$2,177,000 -1.5% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$7,241,000 -$2,002,000 -$680,000 -51.4% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$6,561,000 -$2,137,000 -$803,000 -60.2% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$5,758,000 -$1,609,000 01 Oct 2011 31 Dec 2011 10-Q 14 Aug 2013
Q3 2011 -$1,493,000 +$271,000 +15.4% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 -$1,322,000 +$51,000 +3.7% 01 Apr 2011 30 Jun 2011 10-Q/A 30 Aug 2012
Q1 2011 -$1,334,000 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$1,764,000 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$1,373,000 01 Apr 2010 30 Jun 2010 10-Q 12 Aug 2011

ASENSUS SURGICAL, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$78,433,000 -$2,872,000 -3.8% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2024
2022 -$75,561,000 -$13,099,000 -21% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$62,462,000 -$3,150,000 -5.3% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 -$59,312,000 +$94,889,000 +61.5% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022
2019 -$154,201,000 -$92,424,000 -1.5% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$61,777,000 +$83,019,000 +57.3% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
2017 -$144,796,000 -$24,816,000 -20.7% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2019
2016 -$119,980,000 -$73,032,000 -1.6% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 -$46,948,000 -$9,296,000 -24.7% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 -$37,652,000 -$9,294,000 -32.8% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017
2013 -$28,358,000 -$12,933,000 -83.8% 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016
2012 -$15,425,000 -$9,667,000 -1.7% 01 Jan 2012 31 Dec 2012 10-K 05 Mar 2014
2011 -$5,758,000 -$455,000 -8.6% 01 Jan 2011 31 Dec 2011 10-Q 14 Aug 2013
2010 -$5,303,000 01 Jan 2010 31 Dec 2010 10-Q 14 Aug 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.